Page last updated: 2024-10-31

mitoxantrone and Neoplasms, Otorhinolaryngologic

mitoxantrone has been researched along with Neoplasms, Otorhinolaryngologic in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"Advanced squamous cell carcinomas of the head and neck region were often treated with combined radio-chemotherapy."1.33[Magnetic Drug Targeting--a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies]. ( Alexiou, C; Bergemann, C; Erhardt, W; Iro, H; Jurgons, R; Parak, F; Schmid, R, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexiou, C1
Jurgons, R1
Schmid, R1
Erhardt, W1
Parak, F1
Bergemann, C1
Iro, H1
Simon, C1

Other Studies

2 other studies available for mitoxantrone and Neoplasms, Otorhinolaryngologic

ArticleYear
[Magnetic Drug Targeting--a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies].
    HNO, 2005, Volume: 53, Issue:7

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Drug

2005
[Magnetic drug targeting. New paths for the local concentration of drugs for head and neck cancer].
    HNO, 2005, Volume: 53, Issue:7

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Magnetics

2005